BriaCell Therapeutics Corp.
BCTX · NASDAQ
Market closed$3.73$-0.120000 (-3.12%)After hours $3.71 · -0.54%
Key statistics
Previous close$3.85
Open$3.80
Day high$3.86
Day low$3.73
52-week high$14.68
52-week low$2.60
Market cap7.03M
Volume87.91K
Average volume217.47K
P/E ratio-0.20
Forward P/E—
EPS-18.41
Dividend yield0.00%
Market context
Why it moved
BCTX experienced a modest decline today likely due to low trading volume and broader sector selling pressure, as no specific company-related catalysts were identified to support the prior session's closing price.
What is happening
Recent company-specific developments and publisher coverage.
Kavout | AI · July 18, 2026What Does BriaCell's Latest Offering Mean for Shareholderswww.marketscreener.com · July 16, 2026BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast CancerStock Titan · July 16, 2026Nature Medicine Features BriaCell Trial Among 11 That Will Shape MedicineGlobeNewswire · July 15, 2026BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™Stock Titan · July 15, 2026BriaCell Taps FUJIFILM to Make Breast Cancer Cell TherapyStock Titan · July 7, 2026BriaCell taps CRA and Kaleio for Bria-IMT launch planningStock Titan · June 25, 2026BriaCell plans microneedle delivery scale-up for breast cancer drugStock Titan · May 31, 2026Cancer immunotherapy firm BriaCell raises $4.7M for operations Mt Newswire · July 16, 2026BriaCell Opens First Canadian Site For Phase 3 Metastatic Breast Cancer Study Benzinga · July 16, 2026Odette Cancer Centre At Sunnybrook Health Sciences Centre Joined BriaCell’s Ongoing Pivotal Phase 3 Study Of Bria-IMT Plus Immune Checkpoint Inhibitor In Metastatic Breast Cancer Benzinga · July 15, 2026BriaCell Therapeutics Enters Manufacturing Arrangement With FUJIFILM Biotechnologies To Support Phase 3 Clinical Development And Potential Future Commercial Supply Of Its Allogenic Cell Therapy BRIA-IMT Mt Newswire · July 7, 2026BriaCell Engages Consulting and Branding Firms to Support Potential Commercialization of Bria-IMT Benzinga · July 7, 2026BriaCell Therapeutics Engages Charles River Associates, Kaleio To Explore Commercial Strategy, Market Access Evaluation Of Bria-IMT Mt Newswire · June 25, 2026BriaCell Therapeutics Inks MOU With Dutch Microneedle Company Benzinga · June 25, 2026BriaCell Therapeutics Inks MoU With Uneedle For Continued Use, Commercial Readiness Of Microneedle Technology For Intradermal Administration Of BriaCell’s Bria-IMT Benzinga · June 9, 2026BriaCell Therapeutics Q3 EPS $(0.99) Up From $(16.40) YoY